Article Abstract

Chemoprevention and novel therapy for hepatocellular carcinoma associated with chronic hepatitis B virus infection

Authors: Ih-Jen Su, Wen-Chuan Hsieh, Hung-Wen Tsai, Han-Chieh Wu


Hepatitis B virus (HBV) infection is one of the major risk factors in the development of hepatocullular carcinoma (HCC) worldwide.


  • There are currently no refbacks.